Skip to main content
SpringerLink
Log in

Healthcare costs increase with increased Lp(a) levels

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 10-year Framingham CVD risk >20%, diabetes mellitus, or previous CVD

  2. 2011 US dollars

Reference

  • Zhao Y, et al. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults. Clinical Cardiology : 13 May 2016. Available from: URL: http://doi.org/10.1002/clc.22546

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Healthcare costs increase with increased Lp(a) levels. PharmacoEcon Outcomes News 754, 15 (2016). https://doi.org/10.1007/s40274-016-3085-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3085-2

Search

Navigation